RDCM (NASDAQ: RDCM) insider plans sale of 5,597 ordinary shares

Rhea-AI Filing Summary

A shareholder filed a Form 144 notice indicating an intention to sell 5,597 ordinary shares through Oppenheimer & Co. Inc. on or about 02/12/2026, with an aggregate market value of $66,380.42. The issuer had 15,915,616 shares outstanding. The seller previously disposed of 3,550 ordinary shares on 12/09/2025 for gross proceeds of $49,309.50. The shares to be sold were acquired from the issuer as restricted stock units on multiple dates.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	5597	66380.42	15915616	02/12/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	02/07/2023	Restricted Stock Units	Issuer			9000	02/07/2023	N/A
Ordinary	01/30/2024	Restricted Stock Units	Issuer			27250	01/30/2024	N/A
Ordinary	02/23/2022	Restricted Stock Units	Issuer			15375	02/23/2022	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Hadar Rahav 24 RAOUL WALLENBERG STREET TEL AVIV L3 69719	Ordinary	12/09/2025	3550	49309.50

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for RDCM disclose?

The Form 144 filing discloses a planned sale of 5,597 ordinary shares of RDCM. The proposed sale has an aggregate market value of $66,380.42 and is to be executed through Oppenheimer & Co. Inc. on or about February 12, 2026.

How many RDCM shares are planned for sale under this Form 144?

The filing states that 5,597 ordinary shares of RDCM are planned for sale. These shares are to be sold through Oppenheimer & Co. Inc. on or about February 12, 2026, with a disclosed aggregate market value of $66,380.42.

How many RDCM shares are outstanding according to the Form 144?

The Form 144 lists 15,915,616 ordinary shares outstanding for RDCM. This figure provides context for the planned sale of 5,597 shares, showing the scale of the proposed transaction relative to the total share count.

What prior RDCM share sales are disclosed in the past three months?

The filing reports that the seller disposed of 3,550 ordinary shares of RDCM on December 9, 2025. Those sales generated $49,309.50 in gross proceeds, and must be aggregated with the planned sale for Rule 144 compliance purposes.

How were the RDCM shares in this Form 144 originally acquired?

The Form 144 shows the securities were acquired as restricted stock units from the issuer. Acquisition dates include 02/23/2022, 02/07/2023, and 01/30/2024, with share amounts of 15,375, 9,000, and 27,250 respectively.

Which broker is handling the planned RDCM share sale in the Form 144?

The planned sale of 5,597 ordinary shares of RDCM will be handled by Oppenheimer & Co. Inc., located at 85 Broad Street, New York, NY 10004. The filing also indicates the shares are listed on the Nasdaq exchange.